Last 12 months
Inside the activity.
4 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 1 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 1 | 0 |
| Apr 2026 | 1 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 1 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 30, 2023 Filed Apr 3, 2023 21:42 UTC |
Hoag Erik DCEVP Chief Financial Officer
|
Exercise / conversionCommon Stock | 243 | $0.00 | $0.00 |
DisclosureSEC source: 0001136893-23-000057 · wf-form4_168055810759573.xml · nonDerivative · entry 5 Hoag Erik D · CIK 0001952226 · CEVP Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,119.3876 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 30, 2023 Filed Apr 3, 2023 21:42 UTC |
Hoag Erik DCEVP Chief Financial Officer
|
Tax withholdingCommon Stock | 2,028 | $51.47 | $104,381.16 |
DisclosureSEC source: 0001136893-23-000057 · wf-form4_168055810759573.xml · nonDerivative · entry 4 Hoag Erik D · CIK 0001952226 · CEVP Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,876.3876 F1 · shares: Represents shares to satisfy withholding tax obligation for Restricted Stock Unit vesting. Read SEC document |
| March 30, 2023 Filed Apr 3, 2023 21:42 UTC |
Hoag Erik DCEVP Chief Financial Officer
|
Exercise / conversionCommon Stock | 8,326 | $0.00 | $0.00 |
DisclosureSEC source: 0001136893-23-000057 · wf-form4_168055810759573.xml · nonDerivative · entry 3 Hoag Erik D · CIK 0001952226 · CEVP Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,904.3876 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 30, 2023 Filed Apr 3, 2023 21:42 UTC |
Hoag Erik DCEVP Chief Financial Officer
|
Tax withholdingCommon Stock | 68 | $51.47 | $3,499.96 |
DisclosureSEC source: 0001136893-23-000057 · wf-form4_168055810759573.xml · nonDerivative · entry 2 Hoag Erik D · CIK 0001952226 · CEVP Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,578.3876 F1 · shares: Represents shares to satisfy withholding tax obligation for Restricted Stock Unit vesting. Read SEC document |
| March 30, 2023 Filed Apr 3, 2023 21:42 UTC |
Hoag Erik DCEVP Chief Financial Officer
|
Exercise / conversionCommon Stock | 278 | $0.00 | $0.00 |
DisclosureSEC source: 0001136893-23-000057 · wf-form4_168055810759573.xml · nonDerivative · entry 1 Hoag Erik D · CIK 0001952226 · CEVP Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,646.3876 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 30, 2023 Filed Apr 3, 2023 21:41 UTC |
Ferris StephanieCEO and President
|
GrantRestricted Stock Units · Derivative | 18,713 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001136893-23-000055 · wf-form4_168055806778607.xml · derivative · entry 1 Ferris Stephanie · CIK 0001672787 · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,713 Underlying: Common Stock · 18,713 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of FIS common stock. F2 · shares: Awarded in connection with the certification of goals met for performance share units granted February 28, 2022 for the measurement period ended December 31, 2022. F3 · derivative.exercise_date: The restricted stock units cliff-vest and distribute on February 28, 2025. F3 · derivative.expiration_date: The restricted stock units cliff-vest and distribute on February 28, 2025. Read SEC document |
| March 22, 2023 Filed Mar 24, 2023 20:30 UTC |
LAMNECK KENNETH TDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 526 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001136893-23-000048 · wf-form4_167968983233564.xml · derivative · entry 2 LAMNECK KENNETH T · CIK 0001282998 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 526 shares Expires 2023-03-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 22, 2023 Filed Mar 24, 2023 20:30 UTC |
LAMNECK KENNETH TDirector
|
Exercise / conversionCommon Stock | 526 | $0.00 | $0.00 |
DisclosureSEC source: 0001136893-23-000048 · wf-form4_167968983233564.xml · nonDerivative · entry 1 LAMNECK KENNETH T · CIK 0001282998 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,772 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 22, 2023 Filed Mar 24, 2023 20:30 UTC |
D'Silva VijayDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 526 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001136893-23-000047 · wf-form4_167968981530510.xml · derivative · entry 2 D'Silva Vijay · CIK 0001914834 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 526 shares Expires 2023-03-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 22, 2023 Filed Mar 24, 2023 20:30 UTC |
D'Silva VijayDirector
|
Exercise / conversionCommon Stock | 526 | $0.00 | $0.00 |
DisclosureSEC source: 0001136893-23-000047 · wf-form4_167968981530510.xml · nonDerivative · entry 1 D'Silva Vijay · CIK 0001914834 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,736 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 07, 2023 Filed Mar 9, 2023 21:54 UTC |
Hoag Erik DCEVP Chief Financial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,658 | $62.92 Strike: $62.92 | $356,001.36 |
DisclosureSEC source: 0001136893-23-000044 · wf-form4_167839888437780.xml · derivative · entry 3 Hoag Erik D · CIK 0001952226 · CEVP Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,658 shares Expires 2023-03-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 07, 2023 Filed Mar 9, 2023 21:54 UTC |
Hoag Erik DCEVP Chief Financial Officer
|
SaleCommon Stock | 5,658 | $63.88 | $361,433.04 |
DisclosureSEC source: 0001136893-23-000044 · wf-form4_167839888437780.xml · nonDerivative · entry 2 Hoag Erik D · CIK 0001952226 · CEVP Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,368.3876 F1 · kind: Transacted under a 10b5-1 Plan. Read SEC document |
| March 07, 2023 Filed Mar 9, 2023 21:54 UTC |
Hoag Erik DCEVP Chief Financial Officer
|
Exercise / conversionCommon Stock | 5,658 | $62.92 | $356,001.36 |
DisclosureSEC source: 0001136893-23-000044 · wf-form4_167839888437780.xml · nonDerivative · entry 1 Hoag Erik D · CIK 0001952226 · CEVP Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,026.3876 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transacted under a 10b5-1 Plan. Read SEC document |
| March 01, 2023 Filed Mar 2, 2023 22:55 UTC |
Williams Lenore DCEVP, Chief People Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 1,575 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001136893-23-000042 · wf-form4_167779769316117.xml · derivative · entry 3 Williams Lenore D · CIK 0001730708 · CEVP, Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,150 Underlying: Common Stock · 1,575 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of FIS common stock. F3 · derivative.exercise_date: The restricted stock units vest and distribute in three equal annual installments on each anniversary date. F3 · derivative.expiration_date: The restricted stock units vest and distribute in three equal annual installments on each anniversary date. Read SEC document |
| March 01, 2023 Filed Mar 2, 2023 22:55 UTC |
Williams Lenore DCEVP, Chief People Officer
|
Tax withholdingCommon Stock | 433 | $63.37 | $27,439.21 |
DisclosureSEC source: 0001136893-23-000042 · wf-form4_167779769316117.xml · nonDerivative · entry 2 Williams Lenore D · CIK 0001730708 · CEVP, Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,812.9308 F1 · shares: Represents shares to satisfy withholding tax obligation for Restricted Stock Unit vesting. Read SEC document |
| March 01, 2023 Filed Mar 2, 2023 22:55 UTC |
Williams Lenore DCEVP, Chief People Officer
|
Exercise / conversionCommon Stock | 1,575 | $0.00 | $0.00 |
DisclosureSEC source: 0001136893-23-000042 · wf-form4_167779769316117.xml · nonDerivative · entry 1 Williams Lenore D · CIK 0001730708 · CEVP, Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,245.9308 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2023 Filed Mar 2, 2023 22:54 UTC |
Warren Thomas KChief Accounting Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 420 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001136893-23-000041 · wf-form4_167779767593120.xml · derivative · entry 3 Warren Thomas K · CIK 0001865871 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 840 Underlying: Common Stock · 420 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of FIS common stock. F3 · derivative.exercise_date: The restricted stock units vest and distribute in three equal annual installments on each anniversary date. F3 · derivative.expiration_date: The restricted stock units vest and distribute in three equal annual installments on each anniversary date. Read SEC document |
| March 01, 2023 Filed Mar 2, 2023 22:54 UTC |
Warren Thomas KChief Accounting Officer
|
Tax withholdingCommon Stock | 125 | $63.37 | $7,921.25 |
DisclosureSEC source: 0001136893-23-000041 · wf-form4_167779767593120.xml · nonDerivative · entry 2 Warren Thomas K · CIK 0001865871 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,441.3468 F1 · shares: Represents shares to satisfy withholding tax obligation for Restricted Stock Unit vesting. Read SEC document |
| March 01, 2023 Filed Mar 2, 2023 22:54 UTC |
Warren Thomas KChief Accounting Officer
|
Exercise / conversionCommon Stock | 420 | $0.00 | $0.00 |
DisclosureSEC source: 0001136893-23-000041 · wf-form4_167779767593120.xml · nonDerivative · entry 1 Warren Thomas K · CIK 0001865871 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,555.5919 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2023 Filed Mar 2, 2023 22:54 UTC |
Tsai CarolineCEVP CLO and Corp Affairs
|
Exercise / conversionRestricted Stock Units · Derivative | 2,625 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001136893-23-000040 · wf-form4_167779765256873.xml · derivative · entry 3 Tsai Caroline · CIK 0001723976 · CEVP CLO and Corp Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,251 Underlying: Common Stock · 2,625 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of FIS common stock. F3 · derivative.exercise_date: The restricted stock units vest and distribute in three equal annual installments on each anniversary date. F3 · derivative.expiration_date: The restricted stock units vest and distribute in three equal annual installments on each anniversary date. Read SEC document |
| March 01, 2023 Filed Mar 2, 2023 22:54 UTC |
Tsai CarolineCEVP CLO and Corp Affairs
|
Tax withholdingCommon Stock | 689 | $63.37 | $43,661.93 |
DisclosureSEC source: 0001136893-23-000040 · wf-form4_167779765256873.xml · nonDerivative · entry 2 Tsai Caroline · CIK 0001723976 · CEVP CLO and Corp Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,936 F1 · shares: Represents shares to satisfy withholding tax obligation for Restricted Stock Unit vesting. Read SEC document |
| March 01, 2023 Filed Mar 2, 2023 22:54 UTC |
Tsai CarolineCEVP CLO and Corp Affairs
|
Exercise / conversionCommon Stock | 2,625 | $0.00 | $0.00 |
DisclosureSEC source: 0001136893-23-000040 · wf-form4_167779765256873.xml · nonDerivative · entry 1 Tsai Caroline · CIK 0001723976 · CEVP CLO and Corp Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,625 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2023 Filed Mar 2, 2023 22:54 UTC |
Hoag Erik DCEVP Chief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 1,400 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001136893-23-000039 · wf-form4_167779763356796.xml · derivative · entry 3 Hoag Erik D · CIK 0001952226 · CEVP Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,800 Underlying: Common Stock · 1,400 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of FIS common stock. F3 · derivative.exercise_date: The restricted stock units vest and distribute in three equal annual installments on each anniversary date. F3 · derivative.expiration_date: The restricted stock units vest and distribute in three equal annual installments on each anniversary date. Read SEC document |
| March 01, 2023 Filed Mar 2, 2023 22:54 UTC |
Hoag Erik DCEVP Chief Financial Officer
|
Tax withholdingCommon Stock | 386 | $63.37 | $24,460.82 |
DisclosureSEC source: 0001136893-23-000039 · wf-form4_167779763356796.xml · nonDerivative · entry 2 Hoag Erik D · CIK 0001952226 · CEVP Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,309.1116 F1 · shares: Represents shares to satisfy withholding tax obligation for Restricted Stock Unit vesting. Read SEC document |
| March 01, 2023 Filed Mar 2, 2023 22:54 UTC |
Hoag Erik DCEVP Chief Financial Officer
|
Exercise / conversionCommon Stock | 1,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001136893-23-000039 · wf-form4_167779763356796.xml · nonDerivative · entry 1 Hoag Erik D · CIK 0001952226 · CEVP Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,695.1116 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2023 Filed Mar 2, 2023 22:53 UTC |
Gileadi IdoChief Operating Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 2,520 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001136893-23-000038 · wf-form4_167779761088423.xml · derivative · entry 3 Gileadi Ido · CIK 0001828527 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,041 Underlying: Common Stock · 2,520 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of FIS common stock. F3 · derivative.exercise_date: The restricted stock units vest and distribute in three equal annual installments on each anniversary date. F3 · derivative.expiration_date: The restricted stock units vest and distribute in three equal annual installments on each anniversary date. Read SEC document |
| March 01, 2023 Filed Mar 2, 2023 22:53 UTC |
Gileadi IdoChief Operating Officer
|
Tax withholdingCommon Stock | 653 | $63.37 | $41,380.61 |
DisclosureSEC source: 0001136893-23-000038 · wf-form4_167779761088423.xml · nonDerivative · entry 2 Gileadi Ido · CIK 0001828527 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,818.524 F1 · shares: Represents shares to satisfy withholding tax obligation for Restricted Stock Unit vesting. Read SEC document |
| March 01, 2023 Filed Mar 2, 2023 22:53 UTC |
Gileadi IdoChief Operating Officer
|
Exercise / conversionCommon Stock | 2,520 | $0.00 | $0.00 |
DisclosureSEC source: 0001136893-23-000038 · wf-form4_167779761088423.xml · nonDerivative · entry 1 Gileadi Ido · CIK 0001828527 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,471.524 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2023 Filed Mar 2, 2023 22:53 UTC |
Ferris StephanieCEO and President
|
Exercise / conversionRestricted Stock Units · Derivative | 5,600 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001136893-23-000037 · wf-form4_167779759443940.xml · derivative · entry 3 Ferris Stephanie · CIK 0001672787 · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,201 Underlying: Common Stock · 5,600 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of FIS common stock. F3 · derivative.exercise_date: The restricted stock units vest and distribute in three equal annual installments on each anniversary date. F3 · derivative.expiration_date: The restricted stock units vest and distribute in three equal annual installments on each anniversary date. Read SEC document |
| March 01, 2023 Filed Mar 2, 2023 22:53 UTC |
Ferris StephanieCEO and President
|
Tax withholdingCommon Stock | 1,359 | $63.37 | $86,119.83 |
DisclosureSEC source: 0001136893-23-000037 · wf-form4_167779759443940.xml · nonDerivative · entry 2 Ferris Stephanie · CIK 0001672787 · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,537.321 F1 · shares: Represents shares to satisfy withholding tax obligation for Restricted Stock Unit vesting. Read SEC document |
| March 01, 2023 Filed Mar 2, 2023 22:53 UTC |
Ferris StephanieCEO and President
|
Exercise / conversionCommon Stock | 5,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001136893-23-000037 · wf-form4_167779759443940.xml · nonDerivative · entry 1 Ferris Stephanie · CIK 0001672787 · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,896.321 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2023 Filed Mar 2, 2023 22:55 UTC |
Williams Lenore DCEVP, Chief People Officer
|
GrantStock Option (Right to Buy) · Derivative | 133,077 | $63.37 Strike: $63.37 | $8,433,089.49 |
DisclosureSEC source: 0001136893-23-000042 · wf-form4_167779769316117.xml · derivative · entry 5 Williams Lenore D · CIK 0001730708 · CEVP, Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,077 Underlying: Common Stock · 133,077 shares Expires 2030-02-28 F4 · derivative.exercise_price: The non-qualified stock option was granted as a premium-price stock option. To calculate the premium exercise price for each tranche we used the closing price on February 28, 2023 of $63.37 and multiplied by 15% for tranche 1, 25% for tranche 2 and 30% above for tranche 3. F5 · shares: The non-qualified stock option was granted as a premium-price stock option. 40,373 shares will vest and become exercisable on February 28, 2024 with an exercise price of $72.88, 45,104 shares will vest and become exercisable on February 28, 2025 with an exercise price of $79.21, and 47,600 shares will vest and become exercisable on February 28, 2026 with an exercise price of $82.38. F4 · price: The non-qualified stock option was granted as a premium-price stock option. To calculate the premium exercise price for each tranche we used the closing price on February 28, 2023 of $63.37 and multiplied by 15% for tranche 1, 25% for tranche 2 and 30% above for tranche 3. Read SEC document |
| February 28, 2023 Filed Mar 2, 2023 22:55 UTC |
Williams Lenore DCEVP, Chief People Officer
|
GrantRestricted Stock Units · Derivative | 24,854 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001136893-23-000042 · wf-form4_167779769316117.xml · derivative · entry 4 Williams Lenore D · CIK 0001730708 · CEVP, Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,854 Underlying: Common Stock · 24,854 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of FIS common stock. F3 · derivative.exercise_date: The restricted stock units vest and distribute in three equal annual installments on each anniversary date. F3 · derivative.expiration_date: The restricted stock units vest and distribute in three equal annual installments on each anniversary date. Read SEC document |
| February 28, 2023 Filed Mar 2, 2023 22:54 UTC |
Warren Thomas KChief Accounting Officer
|
GrantStock Option (Right to Buy) · Derivative | 11,829 | $63.37 Strike: $63.37 | $749,603.73 |
DisclosureSEC source: 0001136893-23-000041 · wf-form4_167779767593120.xml · derivative · entry 5 Warren Thomas K · CIK 0001865871 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,829 Underlying: Common Stock · 11,829 shares Expires 2030-02-28 F4 · derivative.exercise_price: The non-qualified stock option was granted as a premium-price stock option. To calculate the premium exercise price for each tranche we used the closing price on February 28, 2023 of $63.37 and multiplied by 15% for tranche 1, 25% for tranche 2 and 30% above for tranche 3. F5 · shares: The non-qualified stock option was granted as a premium-price stock option. 3,589 shares will vest and become exercisable on February 28, 2024 with an exercise price of $72.88, 4,009 shares will vest and become exercisable on February 28, 2025 with an exercise price of $79.21, and 4,231 shares will vest and become exercisable on February 28, 2026 with an exercise price of $82.38. F4 · price: The non-qualified stock option was granted as a premium-price stock option. To calculate the premium exercise price for each tranche we used the closing price on February 28, 2023 of $63.37 and multiplied by 15% for tranche 1, 25% for tranche 2 and 30% above for tranche 3. Read SEC document |
| February 28, 2023 Filed Mar 2, 2023 22:54 UTC |
Warren Thomas KChief Accounting Officer
|
GrantRestricted Stock Units · Derivative | 2,209 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001136893-23-000041 · wf-form4_167779767593120.xml · derivative · entry 4 Warren Thomas K · CIK 0001865871 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,209 Underlying: Common Stock · 2,209 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of FIS common stock. F3 · derivative.exercise_date: The restricted stock units vest and distribute in three equal annual installments on each anniversary date. F3 · derivative.expiration_date: The restricted stock units vest and distribute in three equal annual installments on each anniversary date. Read SEC document |
| February 28, 2023 Filed Mar 2, 2023 22:54 UTC |
Tsai CarolineCEVP CLO and Corp Affairs
|
GrantStock Option (Right to Buy) · Derivative | 133,077 | $63.37 Strike: $63.37 | $8,433,089.49 |
DisclosureSEC source: 0001136893-23-000040 · wf-form4_167779765256873.xml · derivative · entry 5 Tsai Caroline · CIK 0001723976 · CEVP CLO and Corp Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,077 Underlying: Common Stock · 133,077 shares Expires 2030-02-28 F4 · derivative.exercise_price: The non-qualified stock option was granted as a premium-price stock option. To calculate the premium exercise price for each tranche we used the closing price on February 28, 2023 of $63.37 and multiplied by 15% for tranche 1, 25% for tranche 2 and 30% above for tranche 3. F5 · shares: The non-qualified stock option was granted as a premium-price stock option. 40,373 shares will vest and become exercisable on February 28, 2024 with an exercise price of $72.88, 45,104 shares will vest and become exercisable on February 28, 2025 with an exercise price of $79.21, and 47,600 shares will vest and become exercisable on February 28, 2026 with an exercise price of $82.38. F4 · price: The non-qualified stock option was granted as a premium-price stock option. To calculate the premium exercise price for each tranche we used the closing price on February 28, 2023 of $63.37 and multiplied by 15% for tranche 1, 25% for tranche 2 and 30% above for tranche 3. Read SEC document |
| February 28, 2023 Filed Mar 2, 2023 22:54 UTC |
Tsai CarolineCEVP CLO and Corp Affairs
|
GrantRestricted Stock Units · Derivative | 24,854 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001136893-23-000040 · wf-form4_167779765256873.xml · derivative · entry 4 Tsai Caroline · CIK 0001723976 · CEVP CLO and Corp Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,854 Underlying: Common Stock · 24,854 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of FIS common stock. F3 · derivative.exercise_date: The restricted stock units vest and distribute in three equal annual installments on each anniversary date. F3 · derivative.expiration_date: The restricted stock units vest and distribute in three equal annual installments on each anniversary date. Read SEC document |
| February 28, 2023 Filed Mar 2, 2023 22:54 UTC |
Hoag Erik DCEVP Chief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 88,717 | $63.37 Strike: $63.37 | $5,621,996.29 |
DisclosureSEC source: 0001136893-23-000039 · wf-form4_167779763356796.xml · derivative · entry 5 Hoag Erik D · CIK 0001952226 · CEVP Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,717 Underlying: Common Stock · 88,717 shares Expires 2030-02-28 F4 · derivative.exercise_price: The non-qualified stock option was granted as a premium-price stock option. To calculate the premium exercise price for each tranche we used the closing price on February 28, 2023 of $63.37 and multiplied by 15% for tranche 1, 25% for tranche 2 and 30% above for tranche 3. F5 · shares: The non-qualified stock option was granted as a premium-price stock option. 26,915 shares will vest and become exercisable on February 28, 2024 with an exercise price of $72.88, 30,069 shares will vest and become exercisable on February 28, 2025 with an exercise price of $79.21, and 31,733 shares will vest and become exercisable on February 28, 2026 with an exercise price of $82.38. F4 · price: The non-qualified stock option was granted as a premium-price stock option. To calculate the premium exercise price for each tranche we used the closing price on February 28, 2023 of $63.37 and multiplied by 15% for tranche 1, 25% for tranche 2 and 30% above for tranche 3. Read SEC document |
| February 28, 2023 Filed Mar 2, 2023 22:54 UTC |
Hoag Erik DCEVP Chief Financial Officer
|
GrantRestricted Stock Units · Derivative | 16,569 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001136893-23-000039 · wf-form4_167779763356796.xml · derivative · entry 4 Hoag Erik D · CIK 0001952226 · CEVP Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,569 Underlying: Common Stock · 16,569 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of FIS common stock. F3 · derivative.exercise_date: The restricted stock units vest and distribute in three equal annual installments on each anniversary date. F3 · derivative.expiration_date: The restricted stock units vest and distribute in three equal annual installments on each anniversary date. Read SEC document |
| February 28, 2023 Filed Mar 2, 2023 22:53 UTC |
Ferris StephanieCEO and President
|
GrantStock Option (Right to Buy) · Derivative | 491,359 | $63.37 Strike: $63.37 | $31,137,419.83 |
DisclosureSEC source: 0001136893-23-000037 · wf-form4_167779759443940.xml · derivative · entry 5 Ferris Stephanie · CIK 0001672787 · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 491,359 Underlying: Common Stock · 491,359 shares Expires 2030-02-28 F4 · derivative.exercise_price: The non-qualified stock option was granted as a premium-price stock option. To calculate the premium exercise price for each tranche we used the closing price on February 28, 2023 of $63.37 and multiplied by 15% for tranche 1, 25% for tranche 2 and 30% above for tranche 3. F5 · shares: The non-qualified stock option was granted as a premium-price stock option. 149,068 shares will vest and become exercisable on February 28, 2024 with an exercise price of $72.88, 166,538 shares will vest and become exercisable on February 28, 2025 with an exercise price of $79.21, and 175,753 shares will vest and become exercisable on February 28, 2026 with an exercise price of $82.38. F4 · price: The non-qualified stock option was granted as a premium-price stock option. To calculate the premium exercise price for each tranche we used the closing price on February 28, 2023 of $63.37 and multiplied by 15% for tranche 1, 25% for tranche 2 and 30% above for tranche 3. Read SEC document |
| February 28, 2023 Filed Mar 2, 2023 22:53 UTC |
Ferris StephanieCEO and President
|
GrantRestricted Stock Units · Derivative | 66,277 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001136893-23-000037 · wf-form4_167779759443940.xml · derivative · entry 4 Ferris Stephanie · CIK 0001672787 · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,277 Underlying: Common Stock · 66,277 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of FIS common stock. F3 · derivative.exercise_date: The restricted stock units vest and distribute in three equal annual installments on each anniversary date. F3 · derivative.expiration_date: The restricted stock units vest and distribute in three equal annual installments on each anniversary date. Read SEC document |
| February 28, 2023 Filed Mar 1, 2024 21:19 UTC Amendment |
Ferris StephanieCEO and President
|
GrantStock Option (Right to Buy) · Derivative | 175,753 | $82.38 Strike: $82.38 | $14,478,532.14 |
DisclosureSEC source: 0001136893-24-000030 · wk-form4a_1709327938.xml · derivative · entry 3 Ferris Stephanie · CIK 0001672787 · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 175,753 Underlying: Common Stock · 175,753 shares Expires 2030-02-28 F1 · derivative.exercise_price: In a Form 4 filed on March 2, 2023, the reporting person reported receipt of a grant of premium stock options on February 28, 2023 that would vest and become exercisable over three years with a different premium exercise price for each vested tranche. These options should have been reported as three separate grants (rather than one consolidated grant in the same aggregate amount), with 15%, 25%, and 30% premium exercise prices to the closing price on February 28, 2023 of $63.37, and each vesting and becoming exercisable in three equal installments over three years. There were no additional grants of premium stock options made to reporting person in fiscal 2023. F1 · shares: In a Form 4 filed on March 2, 2023, the reporting person reported receipt of a grant of premium stock options on February 28, 2023 that would vest and become exercisable over three years with a different premium exercise price for each vested tranche. These options should have been reported as three separate grants (rather than one consolidated grant in the same aggregate amount), with 15%, 25%, and 30% premium exercise prices to the closing price on February 28, 2023 of $63.37, and each vesting and becoming exercisable in three equal installments over three years. There were no additional grants of premium stock options made to reporting person in fiscal 2023. F2 · shares: The options vest and become exercisable in three equal annual installments on the first, second and third anniversaries of the grant date. F1 · price: In a Form 4 filed on March 2, 2023, the reporting person reported receipt of a grant of premium stock options on February 28, 2023 that would vest and become exercisable over three years with a different premium exercise price for each vested tranche. These options should have been reported as three separate grants (rather than one consolidated grant in the same aggregate amount), with 15%, 25%, and 30% premium exercise prices to the closing price on February 28, 2023 of $63.37, and each vesting and becoming exercisable in three equal installments over three years. There were no additional grants of premium stock options made to reporting person in fiscal 2023. F2 · derivative.exercise_date: The options vest and become exercisable in three equal annual installments on the first, second and third anniversaries of the grant date. Read SEC document |
| February 28, 2023 Filed Mar 1, 2024 21:19 UTC Amendment |
Ferris StephanieCEO and President
|
GrantStock Option (Right to Buy) · Derivative | 166,538 | $79.21 Strike: $79.21 | $13,191,474.98 |
DisclosureSEC source: 0001136893-24-000030 · wk-form4a_1709327938.xml · derivative · entry 2 Ferris Stephanie · CIK 0001672787 · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 166,538 Underlying: Common Stock · 166,538 shares Expires 2030-02-28 F1 · derivative.exercise_price: In a Form 4 filed on March 2, 2023, the reporting person reported receipt of a grant of premium stock options on February 28, 2023 that would vest and become exercisable over three years with a different premium exercise price for each vested tranche. These options should have been reported as three separate grants (rather than one consolidated grant in the same aggregate amount), with 15%, 25%, and 30% premium exercise prices to the closing price on February 28, 2023 of $63.37, and each vesting and becoming exercisable in three equal installments over three years. There were no additional grants of premium stock options made to reporting person in fiscal 2023. F1 · shares: In a Form 4 filed on March 2, 2023, the reporting person reported receipt of a grant of premium stock options on February 28, 2023 that would vest and become exercisable over three years with a different premium exercise price for each vested tranche. These options should have been reported as three separate grants (rather than one consolidated grant in the same aggregate amount), with 15%, 25%, and 30% premium exercise prices to the closing price on February 28, 2023 of $63.37, and each vesting and becoming exercisable in three equal installments over three years. There were no additional grants of premium stock options made to reporting person in fiscal 2023. F2 · shares: The options vest and become exercisable in three equal annual installments on the first, second and third anniversaries of the grant date. F1 · price: In a Form 4 filed on March 2, 2023, the reporting person reported receipt of a grant of premium stock options on February 28, 2023 that would vest and become exercisable over three years with a different premium exercise price for each vested tranche. These options should have been reported as three separate grants (rather than one consolidated grant in the same aggregate amount), with 15%, 25%, and 30% premium exercise prices to the closing price on February 28, 2023 of $63.37, and each vesting and becoming exercisable in three equal installments over three years. There were no additional grants of premium stock options made to reporting person in fiscal 2023. F2 · derivative.exercise_date: The options vest and become exercisable in three equal annual installments on the first, second and third anniversaries of the grant date. Read SEC document |
| February 28, 2023 Filed Mar 1, 2024 21:19 UTC Amendment |
Ferris StephanieCEO and President
|
GrantStock Option (Right to Buy) · Derivative | 149,068 | $72.88 Strike: $72.88 | $10,864,075.84 |
DisclosureSEC source: 0001136893-24-000030 · wk-form4a_1709327938.xml · derivative · entry 1 Ferris Stephanie · CIK 0001672787 · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 149,068 Underlying: Common Stock · 149,068 shares Expires 2030-02-28 F1 · derivative.exercise_price: In a Form 4 filed on March 2, 2023, the reporting person reported receipt of a grant of premium stock options on February 28, 2023 that would vest and become exercisable over three years with a different premium exercise price for each vested tranche. These options should have been reported as three separate grants (rather than one consolidated grant in the same aggregate amount), with 15%, 25%, and 30% premium exercise prices to the closing price on February 28, 2023 of $63.37, and each vesting and becoming exercisable in three equal installments over three years. There were no additional grants of premium stock options made to reporting person in fiscal 2023. F1 · shares: In a Form 4 filed on March 2, 2023, the reporting person reported receipt of a grant of premium stock options on February 28, 2023 that would vest and become exercisable over three years with a different premium exercise price for each vested tranche. These options should have been reported as three separate grants (rather than one consolidated grant in the same aggregate amount), with 15%, 25%, and 30% premium exercise prices to the closing price on February 28, 2023 of $63.37, and each vesting and becoming exercisable in three equal installments over three years. There were no additional grants of premium stock options made to reporting person in fiscal 2023. F2 · shares: The options vest and become exercisable in three equal annual installments on the first, second and third anniversaries of the grant date. F1 · price: In a Form 4 filed on March 2, 2023, the reporting person reported receipt of a grant of premium stock options on February 28, 2023 that would vest and become exercisable over three years with a different premium exercise price for each vested tranche. These options should have been reported as three separate grants (rather than one consolidated grant in the same aggregate amount), with 15%, 25%, and 30% premium exercise prices to the closing price on February 28, 2023 of $63.37, and each vesting and becoming exercisable in three equal installments over three years. There were no additional grants of premium stock options made to reporting person in fiscal 2023. F2 · derivative.exercise_date: The options vest and become exercisable in three equal annual installments on the first, second and third anniversaries of the grant date. Read SEC document |
| February 28, 2023 Filed Mar 1, 2024 21:17 UTC Amendment |
Tsai CarolineCEVP CLO and Corp Affairs
|
GrantStock Option (Right to Buy) · Derivative | 47,600 | $82.38 Strike: $82.38 | $3,921,288.00 |
DisclosureSEC source: 0001136893-24-000028 · wk-form4a_1709327806.xml · derivative · entry 3 Tsai Caroline · CIK 0001723976 · CEVP CLO and Corp Affairs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,600 Underlying: Common Stock · 47,600 shares Expires 2030-02-28 F1 · derivative.exercise_price: In a Form 4 filed on March 2, 2023, the reporting person reported receipt of a grant of premium stock options on February 28, 2023 that would vest and become exercisable over three years with a different premium exercise price for each vested tranche. These options should have been reported as three separate grants (rather than one consolidated grant in the same aggregate amount), with 15%, 25%, and 30% premium exercise prices to the closing price on February 28, 2023 of $63.37, and each vesting and becoming exercisable in three equal installments over three years. There were no additional grants of premium stock options made to reporting person in fiscal 2023. F1 · shares: In a Form 4 filed on March 2, 2023, the reporting person reported receipt of a grant of premium stock options on February 28, 2023 that would vest and become exercisable over three years with a different premium exercise price for each vested tranche. These options should have been reported as three separate grants (rather than one consolidated grant in the same aggregate amount), with 15%, 25%, and 30% premium exercise prices to the closing price on February 28, 2023 of $63.37, and each vesting and becoming exercisable in three equal installments over three years. There were no additional grants of premium stock options made to reporting person in fiscal 2023. F2 · shares: The options vest and become exercisable in three equal annual installments on the first, second and third anniversaries of the grant date. F1 · price: In a Form 4 filed on March 2, 2023, the reporting person reported receipt of a grant of premium stock options on February 28, 2023 that would vest and become exercisable over three years with a different premium exercise price for each vested tranche. These options should have been reported as three separate grants (rather than one consolidated grant in the same aggregate amount), with 15%, 25%, and 30% premium exercise prices to the closing price on February 28, 2023 of $63.37, and each vesting and becoming exercisable in three equal installments over three years. There were no additional grants of premium stock options made to reporting person in fiscal 2023. F2 · derivative.exercise_date: The options vest and become exercisable in three equal annual installments on the first, second and third anniversaries of the grant date. Read SEC document |
| February 28, 2023 Filed Mar 1, 2024 21:17 UTC Amendment |
Tsai CarolineCEVP CLO and Corp Affairs
|
GrantStock Option (Right to Buy) · Derivative | 45,104 | $79.21 Strike: $79.21 | $3,572,687.84 |
DisclosureSEC source: 0001136893-24-000028 · wk-form4a_1709327806.xml · derivative · entry 2 Tsai Caroline · CIK 0001723976 · CEVP CLO and Corp Affairs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,104 Underlying: Common Stock · 45,104 shares Expires 2030-02-28 F1 · derivative.exercise_price: In a Form 4 filed on March 2, 2023, the reporting person reported receipt of a grant of premium stock options on February 28, 2023 that would vest and become exercisable over three years with a different premium exercise price for each vested tranche. These options should have been reported as three separate grants (rather than one consolidated grant in the same aggregate amount), with 15%, 25%, and 30% premium exercise prices to the closing price on February 28, 2023 of $63.37, and each vesting and becoming exercisable in three equal installments over three years. There were no additional grants of premium stock options made to reporting person in fiscal 2023. F1 · shares: In a Form 4 filed on March 2, 2023, the reporting person reported receipt of a grant of premium stock options on February 28, 2023 that would vest and become exercisable over three years with a different premium exercise price for each vested tranche. These options should have been reported as three separate grants (rather than one consolidated grant in the same aggregate amount), with 15%, 25%, and 30% premium exercise prices to the closing price on February 28, 2023 of $63.37, and each vesting and becoming exercisable in three equal installments over three years. There were no additional grants of premium stock options made to reporting person in fiscal 2023. F2 · shares: The options vest and become exercisable in three equal annual installments on the first, second and third anniversaries of the grant date. F1 · price: In a Form 4 filed on March 2, 2023, the reporting person reported receipt of a grant of premium stock options on February 28, 2023 that would vest and become exercisable over three years with a different premium exercise price for each vested tranche. These options should have been reported as three separate grants (rather than one consolidated grant in the same aggregate amount), with 15%, 25%, and 30% premium exercise prices to the closing price on February 28, 2023 of $63.37, and each vesting and becoming exercisable in three equal installments over three years. There were no additional grants of premium stock options made to reporting person in fiscal 2023. F2 · derivative.exercise_date: The options vest and become exercisable in three equal annual installments on the first, second and third anniversaries of the grant date. Read SEC document |
| February 28, 2023 Filed Mar 1, 2024 21:17 UTC Amendment |
Tsai CarolineCEVP CLO and Corp Affairs
|
GrantStock Option (Right to Buy) · Derivative | 40,373 | $72.88 Strike: $72.88 | $2,942,384.24 |
DisclosureSEC source: 0001136893-24-000028 · wk-form4a_1709327806.xml · derivative · entry 1 Tsai Caroline · CIK 0001723976 · CEVP CLO and Corp Affairs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,373 Underlying: Common Stock · 40,373 shares Expires 2030-02-28 F1 · derivative.exercise_price: In a Form 4 filed on March 2, 2023, the reporting person reported receipt of a grant of premium stock options on February 28, 2023 that would vest and become exercisable over three years with a different premium exercise price for each vested tranche. These options should have been reported as three separate grants (rather than one consolidated grant in the same aggregate amount), with 15%, 25%, and 30% premium exercise prices to the closing price on February 28, 2023 of $63.37, and each vesting and becoming exercisable in three equal installments over three years. There were no additional grants of premium stock options made to reporting person in fiscal 2023. F1 · shares: In a Form 4 filed on March 2, 2023, the reporting person reported receipt of a grant of premium stock options on February 28, 2023 that would vest and become exercisable over three years with a different premium exercise price for each vested tranche. These options should have been reported as three separate grants (rather than one consolidated grant in the same aggregate amount), with 15%, 25%, and 30% premium exercise prices to the closing price on February 28, 2023 of $63.37, and each vesting and becoming exercisable in three equal installments over three years. There were no additional grants of premium stock options made to reporting person in fiscal 2023. F2 · shares: The options vest and become exercisable in three equal annual installments on the first, second and third anniversaries of the grant date. F1 · price: In a Form 4 filed on March 2, 2023, the reporting person reported receipt of a grant of premium stock options on February 28, 2023 that would vest and become exercisable over three years with a different premium exercise price for each vested tranche. These options should have been reported as three separate grants (rather than one consolidated grant in the same aggregate amount), with 15%, 25%, and 30% premium exercise prices to the closing price on February 28, 2023 of $63.37, and each vesting and becoming exercisable in three equal installments over three years. There were no additional grants of premium stock options made to reporting person in fiscal 2023. F2 · derivative.exercise_date: The options vest and become exercisable in three equal annual installments on the first, second and third anniversaries of the grant date. Read SEC document |
| February 28, 2023 Filed Mar 1, 2024 21:14 UTC Amendment |
Williams Lenore DCEVP, Chief People Officer
|
GrantStock Option (Right to Buy) · Derivative | 47,600 | $82.38 Strike: $82.38 | $3,921,288.00 |
DisclosureSEC source: 0001136893-24-000025 · wk-form4a_1709327662.xml · derivative · entry 3 Williams Lenore D · CIK 0001730708 · CEVP, Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,600 Underlying: Common Stock · 47,600 shares Expires 2030-02-28 F1 · derivative.exercise_price: In a Form 4 filed on March 2, 2023, the reporting person reported receipt of a grant of premium stock options on February 28, 2023 that would vest and become exercisable over three years with a different premium exercise price for each vested tranche. These options should have been reported as three separate grants (rather than one consolidated grant in the same aggregate amount), with 15%, 25%, and 30% premium exercise prices to the closing price on February 28, 2023 of $63.37, and each vesting and becoming exercisable in three equal installments over three years. There were no additional grants of premium stock options made to reporting person in fiscal 2023. F1 · shares: In a Form 4 filed on March 2, 2023, the reporting person reported receipt of a grant of premium stock options on February 28, 2023 that would vest and become exercisable over three years with a different premium exercise price for each vested tranche. These options should have been reported as three separate grants (rather than one consolidated grant in the same aggregate amount), with 15%, 25%, and 30% premium exercise prices to the closing price on February 28, 2023 of $63.37, and each vesting and becoming exercisable in three equal installments over three years. There were no additional grants of premium stock options made to reporting person in fiscal 2023. F2 · shares: The options vest and become exercisable in three equal annual installments on the first, second and third anniversaries of the grant date. F1 · price: In a Form 4 filed on March 2, 2023, the reporting person reported receipt of a grant of premium stock options on February 28, 2023 that would vest and become exercisable over three years with a different premium exercise price for each vested tranche. These options should have been reported as three separate grants (rather than one consolidated grant in the same aggregate amount), with 15%, 25%, and 30% premium exercise prices to the closing price on February 28, 2023 of $63.37, and each vesting and becoming exercisable in three equal installments over three years. There were no additional grants of premium stock options made to reporting person in fiscal 2023. F2 · derivative.exercise_date: The options vest and become exercisable in three equal annual installments on the first, second and third anniversaries of the grant date. Read SEC document |
| February 28, 2023 Filed Mar 1, 2024 21:14 UTC Amendment |
Williams Lenore DCEVP, Chief People Officer
|
GrantStock Option (Right to Buy) · Derivative | 45,104 | $79.21 Strike: $79.21 | $3,572,687.84 |
DisclosureSEC source: 0001136893-24-000025 · wk-form4a_1709327662.xml · derivative · entry 2 Williams Lenore D · CIK 0001730708 · CEVP, Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,104 Underlying: Common Stock · 45,104 shares Expires 2030-02-28 F1 · derivative.exercise_price: In a Form 4 filed on March 2, 2023, the reporting person reported receipt of a grant of premium stock options on February 28, 2023 that would vest and become exercisable over three years with a different premium exercise price for each vested tranche. These options should have been reported as three separate grants (rather than one consolidated grant in the same aggregate amount), with 15%, 25%, and 30% premium exercise prices to the closing price on February 28, 2023 of $63.37, and each vesting and becoming exercisable in three equal installments over three years. There were no additional grants of premium stock options made to reporting person in fiscal 2023. F1 · shares: In a Form 4 filed on March 2, 2023, the reporting person reported receipt of a grant of premium stock options on February 28, 2023 that would vest and become exercisable over three years with a different premium exercise price for each vested tranche. These options should have been reported as three separate grants (rather than one consolidated grant in the same aggregate amount), with 15%, 25%, and 30% premium exercise prices to the closing price on February 28, 2023 of $63.37, and each vesting and becoming exercisable in three equal installments over three years. There were no additional grants of premium stock options made to reporting person in fiscal 2023. F2 · shares: The options vest and become exercisable in three equal annual installments on the first, second and third anniversaries of the grant date. F1 · price: In a Form 4 filed on March 2, 2023, the reporting person reported receipt of a grant of premium stock options on February 28, 2023 that would vest and become exercisable over three years with a different premium exercise price for each vested tranche. These options should have been reported as three separate grants (rather than one consolidated grant in the same aggregate amount), with 15%, 25%, and 30% premium exercise prices to the closing price on February 28, 2023 of $63.37, and each vesting and becoming exercisable in three equal installments over three years. There were no additional grants of premium stock options made to reporting person in fiscal 2023. F2 · derivative.exercise_date: The options vest and become exercisable in three equal annual installments on the first, second and third anniversaries of the grant date. Read SEC document |
| February 28, 2023 Filed Mar 1, 2024 21:14 UTC Amendment |
Williams Lenore DCEVP, Chief People Officer
|
GrantStock Option (Right to Buy) · Derivative | 40,373 | $72.88 Strike: $72.88 | $2,942,384.24 |
DisclosureSEC source: 0001136893-24-000025 · wk-form4a_1709327662.xml · derivative · entry 1 Williams Lenore D · CIK 0001730708 · CEVP, Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,373 Underlying: Common Stock · 40,373 shares Expires 2030-02-28 F1 · derivative.exercise_price: In a Form 4 filed on March 2, 2023, the reporting person reported receipt of a grant of premium stock options on February 28, 2023 that would vest and become exercisable over three years with a different premium exercise price for each vested tranche. These options should have been reported as three separate grants (rather than one consolidated grant in the same aggregate amount), with 15%, 25%, and 30% premium exercise prices to the closing price on February 28, 2023 of $63.37, and each vesting and becoming exercisable in three equal installments over three years. There were no additional grants of premium stock options made to reporting person in fiscal 2023. F1 · shares: In a Form 4 filed on March 2, 2023, the reporting person reported receipt of a grant of premium stock options on February 28, 2023 that would vest and become exercisable over three years with a different premium exercise price for each vested tranche. These options should have been reported as three separate grants (rather than one consolidated grant in the same aggregate amount), with 15%, 25%, and 30% premium exercise prices to the closing price on February 28, 2023 of $63.37, and each vesting and becoming exercisable in three equal installments over three years. There were no additional grants of premium stock options made to reporting person in fiscal 2023. F2 · shares: The options vest and become exercisable in three equal annual installments on the first, second and third anniversaries of the grant date. F1 · price: In a Form 4 filed on March 2, 2023, the reporting person reported receipt of a grant of premium stock options on February 28, 2023 that would vest and become exercisable over three years with a different premium exercise price for each vested tranche. These options should have been reported as three separate grants (rather than one consolidated grant in the same aggregate amount), with 15%, 25%, and 30% premium exercise prices to the closing price on February 28, 2023 of $63.37, and each vesting and becoming exercisable in three equal installments over three years. There were no additional grants of premium stock options made to reporting person in fiscal 2023. F2 · derivative.exercise_date: The options vest and become exercisable in three equal annual installments on the first, second and third anniversaries of the grant date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.